Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.
about
Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infectionPattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and ChildrenClinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan AfricaLinking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected InfantsImpact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo.Uptake of HIV testing and outcomes within a Community-based Therapeutic Care (CTC) programme to treat severe acute malnutrition in Malawi: a descriptive studySevere morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regionaImmunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda.Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South AfricaLong-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survivalA retrospective study of Human Immunodeficiency Virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South AShort-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapyAssessment of the epidemiology and burden of measles in Southern Mozambique.Realities and Challenges of a Five Year Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe.Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi.Modelling the Contributions of Malaria, HIV, Malnutrition and Rainfall to the Decline in Paediatric Invasive Non-typhoidal Salmonella Disease in MalawiGrowth, developmental, and behavioral outcomes of HIV-affected preschool children in Thailand.Epidemiology of Respiratory Disease in Malawi.High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibodyFatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV CoinfectionChild mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009.Simple markers for the detection of severe immunosuppression in children with HIV infection in highly resource-scarce settings: experience from the Democratic Republic of Congo.Acceptance of HIV testing for children ages 18 months to 13 years identified through voluntary, home-based HIV counseling and testing in western Kenya.PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges.Impact of multi-micronutrient supplementation on growth and morbidity of HIV-infected South African childrenTotal lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothersEffects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review.Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.Home-based care for orphaned children infected with HIV/AIDS in Uganda.Multiple micronutrient supplementation does not reduce diarrhoea morbidity in Ugandan HIV-infected children: a randomised controlled trial.The impact of HIV infection on childhood pneumonia: comparison between developed and developing regions.Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis.To treat or not to treat? No longer a question.Presenting symptoms and signs in children referred for palliative care in Malawi.Viral coinfections among African children infected with human immunodeficiency virus type 1.
P2860
Q24244620-A0333D86-CCBF-46CB-BD6E-E86C11947D88Q26747400-9E13CF40-7520-4469-B9E7-9BA8B1BDDFB1Q26749153-6E61D280-7E21-4DA8-B363-4FD38233E727Q28077904-1CB5E3ED-61CE-490C-A6AD-C649BA4ACF4FQ30370395-B83317B6-2EE5-4B77-8B54-4561A7CE63CFQ30397919-1B3CEFB7-A9C3-4871-8FA3-70CA9AF155CAQ31020587-7573FC62-0E3B-4197-98E2-C986B04027E6Q33308717-7E642EAB-DB4F-457D-AA76-BBA21E83E6D7Q33624111-3D1C463B-333F-4635-AB90-10AB2F6227EBQ33624926-CC1E4D80-119D-4C6D-83B3-BB9F8FF6FE4AQ33972150-A241792A-A9EA-4E18-8A4D-09EF6F25914CQ33987771-937B4204-C3C4-4B56-97B5-FD675E158DE3Q34231039-7443D639-0463-422A-9E51-216AC3C335F9Q34410400-5D33D980-5AAE-4F63-AAEC-B12619291BB6Q34511504-39127536-8FBA-4F72-8DFB-E9BAE713F356Q35065640-24DEBF66-E48D-44C6-B0F2-09DA78240407Q35101274-B5812EC4-5017-4AAA-8589-7CD63861C32EQ35452458-C293BA20-137B-4DF3-98B3-B3DC34D3C8E0Q35729737-CECC5E09-B271-4DD1-B52C-E106D37EEAE2Q35901112-8DFCFA03-8DFB-404B-AA2B-2A7ABEA154F6Q35937990-34C071AF-CFB2-4EAD-8081-B0B4B7936DC1Q36055407-25981C4E-C4B6-482B-9325-901E2D3267B0Q36177513-F40C3C36-F7A7-4DDF-B77A-027921599946Q36279151-8D1E56D1-DA47-4A71-AA69-A5F7E7A5F3BCQ36504397-E4F8B9EC-98D8-4D04-BD68-4D7E5AEFED9CQ36916297-CAD74256-009A-4C07-8B3D-89786DF1AE7EQ37087787-6F21EFF9-2004-4A9E-9B98-3C9CBE9ED3FBQ37286746-F4D00085-1B9C-4129-9BF6-3AF672ADA599Q37290917-6959CC59-68A8-4713-B38F-7210760042D8Q37386643-D9B9AE68-96F0-4837-B9D9-ACB1698CD668Q37411773-953F0166-2B2B-47BC-8669-DD955026CC2AQ37425515-D8C490D0-5CC7-4750-9A09-E6AB0103C543Q37591893-19960A00-6825-4117-82DF-F4E188C3B69BQ38457057-E905281B-6428-483C-83A1-CB7693E48A0CQ38868088-FA64F06C-0912-4846-B9C6-8860F237F227Q38928659-E636D39E-D116-4BFD-9749-3934D6726B0AQ39037971-1D18D0B9-0164-4063-9774-571DB25FC77BQ39982387-2F74EEA8-E3C3-4FD8-87CB-7BA56DD94277Q40443605-1556EB42-F759-4BB9-9377-CDFE31C09CF0Q43049174-11B3C069-C39E-4A82-A958-D7861B08EE6F
P2860
Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.
@en
type
label
Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.
@en
prefLabel
Morbidity among human immunodeficiency virus-1-infected and -uninfected African children.
@en
P2093
P356
P1433
P1476
Morbidity among human immunodeficiency virus-1-infected and -uninfected African children
@en
P2093
D Markakis
D R Hoover
G N Liomba
J D Chiphangwi
L van Der Hoeven
N I Kumwenda
P G Miotti
R L Broadhead
P356
10.1542/PEDS.106.6.E77
P407
P577
2000-12-01T00:00:00Z